You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Quotient's CE-marked MosaiQ COVID-19 Antibody Microarray is designed to detect human immunoglobulin G and M antibodies against SARS-CoV-2.
Novacyt has initially committed to supply 288,000 tests per week to the DHSC, and it has an option to expand the agreement.
Aria Diagnostics said the test collection kits it is supplying to New York City will help ease supply chain issues that have hampered testing.
Under the agreement, Bioneer will supply instruments, nucleic acid extraction reagents, and COVID-19 test kits, which will be placed at medical institutions in Qatar.
Atomo also said it has closed an oversubscribed initial public offering and that it intends to float its shares on the Australian Securities Exchange mid-month.
The Australian Red Cross Blood Service will use the Alinity s System to process its blood tests and improve lab automation.
ProciseDx anticipates bringing rapid, quantitative point-of-care tests to market in 2020 using Lumiphore's metal luminescent reporter technology.
The firms said that their respective technologies are complementary and bridge a technical gap between pathology, radiology, and oncology.
The firms said that Bio-Techne's Ella platform provides the sensitivity needed to provide analysis of the Nf-L biomarker for neurodegenerative diseases.
The agreement covers the manufacture and supply of superparamagnetic particles. T2 Bio will be a non-exclusive reseller of the particles as part of its products.